Amigaba 300 mg/10 mg Tablet
By Amigaba
Rx
10 Tablet in a Strip

Composition
Gabapentin(300mg) + Amitriptyline(10mg)

Manufacturer - Icon Life Sciences
Icon Life Sciences, Div. Of Mesmer Pharmaceuticals, No.202/6, Lane In.30, Phase-II, IDA, Cherlapally, Hyderabad, 500 051 AP

Expires on or after
February, 2027

liver
Amigaba 300 mg/10 mg Tablet should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Amigaba 300 mg/10 mg Tablet in such patients. Consulting your doctor before using this medication is advised to ensure its safe use. It is important to note that the use of Amigaba 300 mg/10 mg Tablet is not recommended for individuals with severe liver disease.

kidney
Limited data indicates Amigaba 300 mg/10 mg Tablet is likely safe for patients with kidney disease. Consult your doctor as dose adjustment may not be necessary.

alcohol
Consult your doctor when consuming alcohol with Amigaba 300 mg/10 mg Tablet. It is not safe to mix alcohol with this medication. Use caution during pregnancy.

driving
Amigaba 300 mg/10 mg Tablet may impact alertness and affect driving ability due to possible side effects.

pregnancy
Amigaba 300 mg/10 mg Tablet may not be safe to use during pregnancy. Limited studies in humans show potential risks, with animal studies indicating harm to the developing baby. Consulting your doctor is important.

breastfeeding
Amigaba 300 mg/10 mg Tablet is likely unsafe during breastfeeding. Limited data indicates the drug can pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹245
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024